Mills & Reeve completes £5m eye-opening investment round

National law firm Mills & Reeve have just completed a £5 million equity round for leading investment group Mercia Technologies PLC into Aston EyeTech Limited, the developer of next generation eye diagnostics equipment.

Aston EyeTech will use the funding to focus on product development and launch of some exciting new products including a mobile diagnostic platform which integrates hardware, artificial intelligence (AI) and large scale data analytics allowing the clinic to travel to the client rather than the other way around. 

Aston EyeTech was spun out from Aston University's School of Optometry in 2014, an international leader in optometry research and professional training. The company received its first seed investment in 2014 from one of the Mercia Growth Funds, managed by Mercia Fund Managers, and since then has grown from developer to equipment manufacturer to full technology solutions provider. The company has the components to disrupt the global optometry industry and this new funding will help it achieve that. 

Mercia Technologies PLC, a UK investment group focused on funding innovative technology businesses, invested alongside a major Asia-based investment syndicate. 

Peter Dines, Head of Life Sciences and Biosciences at Mercia Technologies PLC, said: “We invested in Aston EyeTech from our managed funds right at the beginning, following its spinout from Aston University. We’ve seen the business grow rapidly with an impressive team of people who push at the boundaries of this fascinating sector.” 

“Working with Mills & Reeve on another deal has, as always, been a pleasure. They understand us, and in turn, understand the businesses we invest in. Their support and enthusiasm in our vision means that they approach the deal with real commercial pragmatism, and get it done quickly and efficiently with minimum interruption to day-to-day business.” 

Carl Francis, Chief Executive of Aston EyeTech said: “With our cutting-edge technology, skilled team and supportive shareholders, Aston EyeTech has all the ingredients needed to disrupt the $200.0billion global eye health care industry. It is personally gratifying to see high quality investors, such as Mercia and our new Asian partners, attracted to this significant opportunity.” 

Zickie Lim, Partner at Mills & Reeve said: “It’s great to have completed another investment for Mercia Technologies into one of their Rising Stars from their Growth Funds portfolio. We’re always excited to be involved in an investment that opens up so many opportunities for a business to scale and expand both nationally and internationally.” 

Our content explained

Every piece of content we create is correct on the date it’s published but please don’t rely on it as legal advice. If you’d like to speak to us about your own legal requirements, please contact one of our expert lawyers.

Mills & Reeve Sites navigation
A tabbed collection of Mills & Reeve sites.
My Mills & Reeve navigation
Subscribe to, or manage your My Mills & Reeve account.
My M&R


Register for My M&R to stay up-to-date with legal news and events, create brochures and bookmark pages.

Existing clients

Log in to your client extranet for free matter information, know-how and documents.


Mills & Reeve system for employees.